These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


196 related items for PubMed ID: 21440575

  • 21. Age-dependent phenotypic characteristics of a triple transgenic mouse model of Alzheimer disease.
    Pietropaolo S, Feldon J, Yee BK.
    Behav Neurosci; 2008 Aug; 122(4):733-47. PubMed ID: 18729626
    [Abstract] [Full Text] [Related]

  • 22. Intracranial administration of vaccinia virus complement control protein in Mo/Hu APPswe PS1dE9 transgenic mice at an early age shows enhanced performance at a later age using a cheese board maze test.
    Kulkarni AP, Pillay NS, Kellaway LA, Kotwal GJ.
    Biogerontology; 2008 Dec; 9(6):405-20. PubMed ID: 18679819
    [Abstract] [Full Text] [Related]

  • 23. Early memory deficits precede plaque deposition in APPswe/PS1dE9 mice: involvement of oxidative stress and cholinergic dysfunction.
    Zhang W, Bai M, Xi Y, Hao J, Liu L, Mao N, Su C, Miao J, Li Z.
    Free Radic Biol Med; 2012 Apr 15; 52(8):1443-52. PubMed ID: 22342520
    [Abstract] [Full Text] [Related]

  • 24. Behavioral abnormalities in APPSwe/PS1dE9 mouse model of AD-like pathology: comparative analysis across multiple behavioral domains.
    Janus C, Flores AY, Xu G, Borchelt DR.
    Neurobiol Aging; 2015 Sep 15; 36(9):2519-32. PubMed ID: 26089165
    [Abstract] [Full Text] [Related]

  • 25. Progressive Spatial Memory Impairment, Brain Amyloid Deposition and Changes in Serum Amyloid Levels as a Function of Age in APPswe/PS1dE9 Mice.
    Fu L, Sun Y, Guo Y, Yu B, Zhang H, Wu J, Yu X, Wu H, Kong W.
    Curr Alzheimer Res; 2018 Sep 15; 15(11):1053-1061. PubMed ID: 29984654
    [Abstract] [Full Text] [Related]

  • 26. Early discrimination reversal learning impairment and preserved spatial learning in a longitudinal study of Tg2576 APPsw mice.
    Zhuo JM, Prescott SL, Murray ME, Zhang HY, Baxter MG, Nicolle MM.
    Neurobiol Aging; 2007 Aug 15; 28(8):1248-57. PubMed ID: 16828204
    [Abstract] [Full Text] [Related]

  • 27. Cognitive and non-cognitive behaviors in an APPswe/PS1 bigenic model of Alzheimer's disease.
    Filali M, Lalonde R, Rivest S.
    Genes Brain Behav; 2009 Mar 15; 8(2):143-8. PubMed ID: 19077180
    [Abstract] [Full Text] [Related]

  • 28. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Izco M, Martínez P, Corrales A, Fandos N, García S, Insua D, Montañes M, Pérez-Grijalba V, Rueda N, Vidal V, Martínez-Cué C, Pesini P, Sarasa M.
    Neuroscience; 2014 Mar 28; 263():269-79. PubMed ID: 24447596
    [Abstract] [Full Text] [Related]

  • 29. Impaired Pavlovian cued fear conditioning in Tg2576 mice expressing a human mutant amyloid precursor protein gene.
    Barnes P, Good M.
    Behav Brain Res; 2005 Feb 10; 157(1):107-17. PubMed ID: 15617777
    [Abstract] [Full Text] [Related]

  • 30. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease.
    Imbimbo BP, Giardino L, Sivilia S, Giuliani A, Gusciglio M, Pietrini V, Del Giudice E, D'Arrigo A, Leon A, Villetti G, Calzà L.
    J Alzheimers Dis; 2010 Feb 10; 20(1):159-73. PubMed ID: 20164581
    [Abstract] [Full Text] [Related]

  • 31. Circadian system functionality, hippocampal oxidative stress, and spatial memory in the APPswe/PS1dE9 transgenic model of Alzheimer disease: effects of melatonin or ramelteon.
    Baño Otalora B, Popovic N, Gambini J, Popovic M, Viña J, Bonet-Costa V, Reiter RJ, Camello PJ, Rol MÁ, Madrid JA.
    Chronobiol Int; 2012 Aug 10; 29(7):822-34. PubMed ID: 22823866
    [Abstract] [Full Text] [Related]

  • 32. Comparative studies using the Morris water maze to assess spatial memory deficits in two transgenic mouse models of Alzheimer's disease.
    Edwards SR, Hamlin AS, Marks N, Coulson EJ, Smith MT.
    Clin Exp Pharmacol Physiol; 2014 Oct 10; 41(10):798-806. PubMed ID: 25115283
    [Abstract] [Full Text] [Related]

  • 33. Use of artificial neural networks to determine cognitive impairment and therapeutic effectiveness in Alzheimer's transgenic mice.
    Leighty RE, Runfeldt MJ, Berndt DJ, Schleif WS, Cracchiolo JR, Potter H, Arendash GW.
    J Neurosci Methods; 2008 Jan 30; 167(2):358-66. PubMed ID: 17904642
    [Abstract] [Full Text] [Related]

  • 34. The Effects of Cardiotrophin-1 on Early Synaptic Mitochondrial Dysfunction and Synaptic Pathology in APPswe/PS1dE9 Mice.
    Wang D, Liu X, Liu Y, Li S, Wang C.
    J Alzheimers Dis; 2017 Jan 30; 59(4):1255-1267. PubMed ID: 28731433
    [Abstract] [Full Text] [Related]

  • 35. Abnormal Clock Gene Expression and Locomotor Activity Rhythms in Two Month-Old Female APPSwe/PS1dE9 Mice.
    Oyegbami O, Collins HM, Pardon MC, Ebling FJP, Heery DM, Moran PM.
    Curr Alzheimer Res; 2017 Jan 30; 14(8):850-860. PubMed ID: 28317486
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
    Pihlaja R, Koistinaho J, Malm T, Sikkilä H, Vainio S, Koistinaho M.
    Glia; 2008 Jan 15; 56(2):154-63. PubMed ID: 18004725
    [Abstract] [Full Text] [Related]

  • 38. Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease.
    Reiserer RS, Harrison FE, Syverud DC, McDonald MP.
    Genes Brain Behav; 2007 Feb 15; 6(1):54-65. PubMed ID: 17233641
    [Abstract] [Full Text] [Related]

  • 39. The anaphase promoting complex is required for memory function in mice.
    Kuczera T, Stilling RM, Hsia HE, Bahari-Javan S, Irniger S, Nasmyth K, Sananbenesi F, Fischer A.
    Learn Mem; 2011 Jan 15; 18(1):49-57. PubMed ID: 21191042
    [Abstract] [Full Text] [Related]

  • 40. Cardiotrophin-1 (CTF1) ameliorates glucose-uptake defects and improves memory and learning deficits in a transgenic mouse model of Alzheimer's disease.
    Wang D, Li X, Gao K, Lu D, Zhang X, Ma C, Ye F, Zhang L.
    Pharmacol Biochem Behav; 2013 Jun 15; 107():48-57. PubMed ID: 23541490
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.